Article Text

Download PDFPDF
A polymorphism in the gene encoding the Fcγ IIIA receptor is a possible genetic marker to predict the primary response to infliximab in Japanese patients with rheumatoid arthritis

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests: None.

  • Funding: Supported by grants provided by the Japan Orthopaedics and Traumatology Foundation (KI), Takeda Science Foundation (KI), and the Japanese Ministry of Education, Culture, Sports, Science and Technology (KI, ST)